Issa Mohamed Khairie
SEC CIK 2050035 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| INCY | Incyte | EVP, Head of US Oncology | 63.9K | — | $1.31M | 8 | 2025-01-06 | 2026-07-16 |
Most active insiders at INCY, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Hoppenot Herve | Dir | — | $19.77M |
| 2 | CAGNONI PABLO J | Pres, R, D | — | $14.10M |
| 3 | Stein Steven H | EVP, Chief Medical Off | — | $7.86M |
| 4 | Mayes Patrick A | EVP, CSO | — | $6.56M |
| 5 | Morrissey Michael James | EVP, Head of Tech. Ops | — | $5.68M |
| 6 | Clancy Paul J | Dir | — | $1.42M |
| 7 | Issa Mohamed Khairie | EVP, Head of US Oncology | — | $1.31M |
| 8 | Tray Thomas | Principal Accounting Off | — | $879.0K |
| 9 | Denton Sheila A. | EVP, GC | — | $465.2K |
| 10 | Heeson Lee | EVP, Head of Incyte Intl | — | $289.0K |
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-07-20 16:09 | 2026-07-16 | INCY | Incyte | Issa Mohamed Khairie | EVP, Head of U.S. Commercial | S - Sale | $115.01 | -1,093 | 63.9K | -2% | -$125.7K |
| DT | 2026-07-20 16:09 | 2026-07-16 | INCY | Incyte | Issa Mohamed Khairie | EVP, Head of U.S. Commercial | A - Grant | $0.00 | +7,857 | 71.8K | +12% | $0 |
| 2026-07-16 16:06 | 2026-07-15 | INCY | Incyte | Issa Mohamed Khairie | EVP, Head of U.S. Commercial | F - Tax | $115.09 | -1,099 | 65.0K | -2% | -$126.5K | |
| 2026-01-08 | 2026-01-06 | INCY | Incyte | Issa Mohamed Khairie | EVP, Head of US Oncology | F - Tax | $106.66 | -8,264 | 77.0K | -10% | -$881.4K | |
| 2026-01-08 | 2026-01-07 | INCY | Incyte | Issa Mohamed Khairie | EVP, Head of US Oncology | S - Sale | $109.07 | -10.9K | 66.1K | -14% | -$1.18M | |
| D | 2025-07-17 | 2025-07-15 | INCY | Incyte | Issa Mohamed Khairie | EVP, Head of US Oncology | A - Grant | $0.00 | +8,769 | 85.3K | +11% | $0 |
| 2025-07-02 | 2025-06-30 | INCY | Incyte | Issa Mohamed Khairie | EVP, Head of US Oncology | A - Grant | $0.00 | +27.8K | 76.5K | +57% | $0 | |
| 2025-01-08 | 2025-01-06 | INCY | Incyte | Issa Mohamed Khairie | EVP, Head of US Oncology | A - Grant | $0.00 | +48.7K | 48.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations